相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
Shigeru Kotake et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Therapeutic implications of osteoprotegerin
Sofia Fili et al.
CANCER CELL INTERNATIONAL (2009)
Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10
Seung-Ha Yang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis
Nicole C. Walsh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Lisgand 2-Dependent Manner
Moutih Rafei et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-κB Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
Kyung-Hyun Park-Min et al.
JOURNAL OF IMMUNOLOGY (2009)
Why are MSCs therapeutic? New data: new insight
Al Caplan
JOURNAL OF PATHOLOGY (2009)
Osteoimmunology and the effects of the immune system on bone
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2009)
Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases
Farida Djouad et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2008)
Interleukin-6 inhibits receptor activator of nuclear factor κB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage:: Key role of Serine727 phosphorylation of signal transducer and activator of transcription 3
Laurence Duplomb et al.
ENDOCRINOLOGY (2008)
Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways
Fumio Yoshitake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)
Tsutomu Takeuchi et al.
MODERN RHEUMATOLOGY (2008)
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari et al.
BLOOD (2008)
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis
Andrea Augello et al.
ARTHRITIS AND RHEUMATISM (2007)
Multipotent mesenchymal stromal cells and immune tolerance
Daniele Noel et al.
LEUKEMIA & LYMPHOMA (2007)
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Kazuya Sato et al.
BLOOD (2007)
Impaired skeletal development in interleukin-6-transgenic mice - A model for the impact of chronic inflammation on the growing skeletal system
Fabrizio De Benedetti et al.
ARTHRITIS AND RHEUMATISM (2006)
Mesenchymal stem cells as trophic mediators
Arnold I. Caplan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Prostaglandin E2 strongly inhibits human osteoclast formation
I Take et al.
ENDOCRINOLOGY (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
XX Jiang et al.
BLOOD (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
E Klyushnenkova et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Plasticity of human adipose lineage cells toward endothelial cells -: Physiological and therapeutic perspectives
V Planat-Benard et al.
CIRCULATION (2004)
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
O Kudo et al.
BONE (2003)
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis
E Romas et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis
H Min et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
N Udagawa et al.
ENDOCRINOLOGY (2000)
分享论文
